20 (AIDX) Free Cash Flow (2025 - 2026)
20 (AIDX) reported Free Cash Flow of -$1.3 million for Q1 2026, down 163.97% on a YoY basis from $2.0 million in Q1 2025, and down 163.97% quarter-over-quarter from -$488293.0 in Q1 2025.
20 (AIDX) Free Cash Flow (2025 - 2026) Analysis & Trends
20 has reported Free Cash Flow for 2 years, with the latest figure at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 163.97% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$1.8 million (changed N/A YoY), and the FY2025 full-year result was -$1.9 million, up 27.75% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.3 million, down from -$488293.0 in the prior quarter.
- The five-year high for Free Cash Flow was -$488293.0 in Q1 2025, with the low at -$1.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | 20 | - | - | 62,884.00 | -1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2025 | -488,293.00 |
| Mar 31, 2025 | -488,293.00 |